Shuttle Pharmaceuticals

SHPH

Q2 FY2026 Earnings

Financial report interval: 2026.03.30 - 2026.06.30

Overview: Shuttle Pharmaceuticals(SHPH) the EBIT is -3.95 M (-1%);the EPS is -3.1 (+90.59%).

Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B1.00%
----
----
EPS
-3.098590.59%
----
----

Upcoming earnings report - Q3 FY2026

Available dateNov 13, 2026
Estimate Revenue--
Estimate EBIT--
Estimate EPS--

Revenue

ActualEstimateUnit: USD
Quarterly

EBIT

ActualEstimateUnit: USD
Quarterly

Net income

ActualEstimateUnit: USD
Quarterly

EPS

ActualEstimateUnit: USD
Quarterly